CLSA maintains high conviction on Bandhan Bank with enhancements in secured assets and technology as key priorities. Jefferies retains 'buy' on Infosy ...

Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...

In the Trump 2.0 era, India’s pivot toward bilateral trade deals with trusted Western economies has become a necessity rather ...

The Nifty Pharma index closed on a negative note on Tuesday. Shares of J B Chemicals & Pharmaceuticals Ltd.(up 3.03 per cent) ...

AM(IST)on Tuesday in an upbeat market. Abbott India Ltd.(up 0.74 per cent), Gland Pharma Ltd.(up 0.68 per cent), Biocon ...

President Donald Trump and his administration have been promoting April 2 as a kind of tariffs Super Bowl, during which all ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Eli Lilly (LLY) stock in focus as the company launches its weight loss therapy Mounjaro in India, beating its rival Novo Nordisk (NVO). Read more here.

India’s biggest pharma company said in a press release filed with the stock exchanges in Mumbai on March 10. The deal will bring Unloxcyt (cosibelimab-ipdl), the first and only FDA-approved anti ...

Sun Pharma, India's largest pharmaceutical company ... for each share of common stock they hold, an upfront cash payment of $4.1. The transaction is subject to Checkpoint’s shareholder and ...